1. Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer. (2nd June 2016) Authors: Dellis, Athanasios; Papatsoris, Athanasios G. Journal: Expert opinion on investigational drugs Issue: Volume 25:Number 6(2016:Jun.) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗